|
CENPBD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02140518265514E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.0430000003997E-08 |
| Normal-vs-Stage2 |
2.30619999985748E-07 |
| Normal-vs-Stage3 |
1.69886327228141E-12 |
| Normal-vs-Stage4 |
2.55351295663786E-15 |
| Stage1-vs-Stage2 |
3.485800E-02 |
| Stage1-vs-Stage3 |
1.02360000031609E-07 |
| Stage1-vs-Stage4 |
4.32960001184313E-09 |
| Stage2-vs-Stage3 |
1.187400E-01 |
| Stage2-vs-Stage4 |
1.809950E-02 |
| Stage3-vs-Stage4 |
2.055000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62569957495862E-12 |
| Normal-vs-AfricanAmerican |
3.53060000000127E-05 |
| Normal-vs-Asian |
3.995400E-01 |
| Caucasian-vs-AfricanAmerican |
4.712800E-01 |
| Caucasian-vs-Asian |
5.493500E-02 |
| AfricanAmerican-vs-Asian |
2.599200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44249065417534E-15 |
| Normal-vs-Female |
1.10910003403575E-09 |
| Male-vs-Female |
3.584400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.29689999999838E-05 |
| Normal-vs-Age(41-60Yrs) |
5.0950998975452E-10 |
| Normal-vs-Age(61-80Yrs) |
1.63669078290241E-12 |
| Normal-vs-Age(81-100Yrs) |
5.67299999999493E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.143800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.740800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.396600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.459600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.889000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.487200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.046450E-01 |
| Normal-vs-Grade 2 |
3.76749997865744E-09 |
| Normal-vs-Grade 3 |
1.71662684067542E-12 |
| Normal-vs-Grade 4 |
3.33066907387547E-16 |
| Grade 1-vs-Grade 2 |
3.074800E-01 |
| Grade 1-vs-Grade 3 |
4.982200E-02 |
| Grade 1-vs-Grade 4 |
1.198040E-02 |
| Grade 2-vs-Grade 3 |
5.838100E-03 |
| Grade 2-vs-Grade 4 |
6.80820000376059E-09 |
| Grade 3-vs-Grade 4 |
3.998100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.29140000307382E-08 |
| Normal-vs-ccB subtype |
1.62625468647093E-12 |
| ccA subtype-vs-ccB subtype |
2.36719999999746E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.23554508238522E-12 |
| Normal-vs-N1 |
1.55491999999091E-05 |
| N0-vs-N1 |
1.438950E-01 |
|
|
